Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis

被引:0
作者
Ito, Hayato [1 ]
Tamura, Tomokazu [1 ,2 ,3 ]
Wang, Lei [4 ,5 ]
Mori, Kento [1 ]
Tsuda, Masumi [4 ,5 ]
Suzuki, Rigel [1 ,2 ]
Suzuki, Saori [1 ,2 ]
Yoshimatsu, Kumiko [6 ]
Tanaka, Shinya [4 ,5 ]
Fukuhara, Takasuke [1 ,2 ,3 ,7 ,8 ]
机构
[1] Hokkaido Univ, Fac Med, Dept Microbiol & Immunol, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Inst Vaccine Res & Dev IVReD, Sapporo, Japan
[3] Hokkaido Univ, One Hlth Res Ctr, Sapporo, Japan
[4] Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido 0608638, Japan
[5] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Japan
[6] Hokkaido Univ, Inst Genet Med, Sapporo, Japan
[7] Osaka Univ, Res Inst Microbial Dis, Lab Virus Control, Suita, Japan
[8] Japan Agcy Med Res & Dev AMED, AMED CREST, Tokyo, Japan
关键词
accessory proteins; immune response; immunopathogenicity; recombinant virus; SARS-CoV-2; VIROLOGICAL CHARACTERISTICS;
D O I
10.1111/1348-0421.13157
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the largest single-stranded RNA virus known to date. Its genome contains multiple accessory protein genes that act against host immune responses but are not required for progeny virus production. The functions of the accessory proteins in the viral life cycle have been examined, but their involvement in viral pathogenicity remains unclear. Here, we investigated the roles of the accessory proteins in viral immunopathogenicity. To this end, recombinant SARS-CoV-2 possessing nonsense mutations in the seven accessory protein open reading frames (ORFs) (ORF3a, ORF3b, ORF6, ORF7a, ORF8, ORF9b, and ORF10) was de novo generated using an early pandemic SARS-CoV-2 strain as a backbone. We confirmed that the resultant virus (termed ORF3-10 KO) did not express accessory proteins in infected cells and retained the desired mutations in the viral genome. In cell culture, the ORF3-10 KO virus exhibited similar virus growth kinetics as the parental virus. In hamsters, ORF3-10 KO virus infection resulted in mild weight loss and reduced viral replication in the oral cavity and lung tissue. ORF3-10 KO virus infection led to mild inflammation, indicating that an inability to evade innate immune sensing because of a lack of accessory proteins impairs virus growth in vivo and results in quick elimination from the body. Overall, we showed that SARS-CoV-2 accessory proteins are involved in immunopathogenicity.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 32 条
[1]  
Arshad N, 2023, P NATL ACAD SCI USA, V120, DOI [10.1073/pnas.2208525120, 10.1101/2022.05.17.492198]
[2]   Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model [J].
Bessiere, Pierre ;
Wasniewski, Marine ;
Picard-Meyer, Evelyne ;
Servat, Alexandre ;
Figueroa, Thomas ;
Foret-Lucas, Charlotte ;
Coggon, Amelia ;
Lesellier, Sandrine ;
Boue, Frank ;
Cebron, Nathan ;
Gausseres, Blandine ;
Trumel, Catherine ;
Foucras, Gilles ;
Salguero, Francisco J. ;
Monchatre-Leroy, Elodie ;
Volmer, Romain .
PLOS PATHOGENS, 2021, 17 (08)
[3]   Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response [J].
Cao, Zengguo ;
Xia, Hongjie ;
Rajsbaum, Ricardo ;
Xia, Xianzhu ;
Wang, Hualei ;
Shi, Pei-Yong .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (03) :746-748
[4]   Characteristics of SARS-CoV-2 and COVID-19 [J].
Hu, Ben ;
Guo, Hua ;
Zhou, Peng ;
Shi, Zheng-Li .
NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) :141-154
[5]   Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant [J].
Ito, Jumpei ;
Suzuki, Rigel ;
Uriu, Keiya ;
Itakura, Yukari ;
Zahradnik, Jiri ;
Kimura, Kanako Terakado ;
Deguchi, Sayaka ;
Wang, Lei ;
Lytras, Spyros ;
Tamura, Tomokazu ;
Kida, Izumi ;
Nasser, Hesham ;
Shofa, Maya ;
Begum, Mst Monira ;
Tsuda, Masumi ;
Oda, Yoshitaka ;
Suzuki, Tateki ;
Sasaki, Jiei ;
Sasaki-Tabata, Kaori ;
Fujita, Shigeru ;
Yoshimatsu, Kumiko ;
Ito, Hayato ;
Nao, Naganori ;
Asakura, Hiroyuki ;
Nagashima, Mami ;
Sadamasu, Kenji ;
Yoshimura, Kazuhisa ;
Yamamoto, Yuki ;
Nagamoto, Tetsuharu ;
Kuramochi, Jin ;
Schreiber, Gideon ;
Saito, Akatsuki ;
Matsuno, Keita ;
Takayama, Kazuo ;
Hashiguchi, Takao ;
Tanaka, Shinya ;
Fukuhara, Takasuke ;
Ikeda, Terumasa ;
Sato, Kei ;
Suzuki, Saori ;
Kato, Marie ;
Ferdous, Zannatul ;
Mouri, Hiromi ;
Shishido, Kenji ;
Misawa, Naoko ;
Kimura, Izumi ;
Kosugi, Yusuke ;
Lin, Pan ;
Suganami, Mai ;
Chiba, Mika .
NATURE COMMUNICATIONS, 2023, 14 (01)
[6]   SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 [J].
Jiang, He-wei ;
Zhang, Hai-nan ;
Meng, Qing-feng ;
Xie, Jia ;
Li, Yang ;
Chen, Hong ;
Zheng, Yun-xiao ;
Wang, Xue-ning ;
Qi, Huan ;
Zhang, Jing ;
Wang, Pei-Hui ;
Han, Ze-Guang ;
Tao, Sheng-ce .
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (09) :998-1000
[7]   Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5 [J].
Kimura, Izumi ;
Yamasoba, Daichi ;
Tamura, Tomokazu ;
Nao, Naganori ;
Suzuki, Tateki ;
Oda, Yoshitaka ;
Mitoma, Shuya ;
Ito, Jumpei ;
Nasser, Hesham ;
Zahradnik, Jiri ;
Uriu, Keiya ;
Fujita, Shigeru ;
Kosugi, Yusuke ;
Wang, Lei ;
Tsuda, Masumi ;
Kishimoto, Mai ;
Ito, Hayato ;
Suzuki, Rigel ;
Shimizu, Ryo ;
Begum, Mst Monira ;
Yoshimatsu, Kumiko ;
Kimura, Kanako Terakado ;
Sasaki, Jiei ;
Sasaki-Tabata, Kaori ;
Yamamoto, Yuki ;
Nagamoto, Tetsuharu ;
Kanamune, Jun ;
Kobiyama, Kouji ;
Asakura, Hiroyuki ;
Nagashima, Mami ;
Sadamasu, Kenji ;
Yoshimura, Kazuhisa ;
Shirakawa, Kotaro ;
Takaori-Kondo, Akifumi ;
Kuramochi, Jin ;
Schreiber, Gideon ;
Ishii, Ken J. ;
Hashiguchi, Takao ;
Ikeda, Terumasa ;
Saito, Akatsuki ;
Fukuhara, Takasuke ;
Tanaka, Shinya ;
Matsuno, Keita ;
Sato, Kei .
CELL, 2022, 185 (21) :3992-+
[8]   SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses [J].
Kohyama, Masako ;
Suzuki, Tatsuya ;
Nakai, Wataru ;
Ono, Chikako ;
Matsuoka, Sumiko ;
Iwatani, Koichi ;
Liu, Yafei ;
Sakai, Yusuke ;
Nakagawa, Atsushi ;
Tomii, Keisuke ;
Ohmura, Koichiro ;
Okada, Masato ;
Matsuura, Yoshiharu ;
Ohshima, Shiro ;
Maeda, Yusuke ;
Okamoto, Toru ;
Arase, Hisashi .
INTERNATIONAL IMMUNOLOGY, 2023, 35 (01) :43-52
[9]   SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant [J].
Konno, Yoriyuki ;
Kimura, Izumi ;
Uriu, Keiya ;
Fukushi, Masaya ;
Irie, Takashi ;
Koyanagi, Yoshio ;
Sauter, Daniel ;
Gifford, Robert J. ;
Nakagawa, So ;
Sato, Kei .
CELL REPORTS, 2020, 32 (12)
[10]   SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy [J].
Li, Xingyu ;
Hou, Peili ;
Ma, Wenqing ;
Wang, Xuefeng ;
Wang, Hongmei ;
Yu, Zhangping ;
Chang, Huasong ;
Wang, Tiecheng ;
Jin, Song ;
Wang, Xue ;
Wang, Wenqi ;
Zhao, Yudong ;
Zhao, Yong ;
Xu, Chunqing ;
Ma, Xiaomei ;
Gao, Yuwei ;
He, Hongbin .
CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (01) :67-78